title: Endocarditis caused by coagulase-negative staphylococci.
abstract: Sixteen patients with coagulase-negative staphylococcal endocarditis were treated at the University of Minnesota Hospitals between January 1970 and September 1977. In six patients, endocarditis developed after prosthetic valve surgery; among the other ten patients (the medical group), eight had known antecedent valvular disease. The skin was thought to be the source of infection in eight patients, suggesting that prompt treatment of skin infections and avoidance of injections in patients with valvular disease are important measures in the prevention of this disease. Patients with prosthetic valve endocarditis were infected with antibiotic-resistant organisms and had a higher mortality than those in the medical group (83% versus 20%). Bacterial isolates from three patients with prosthetic valve endocarditis were resistant to methicillin, and two of these three isolates also were resistant to cephalothin by quantitative susceptibility testing. The only patient with prosthetic valve endocarditis to survive was operated upon early in the course of his illness. These observation, coupled with the high mortality in this series and in others, has prompted us to advocate early surgery in prosthetic valve endocarditis.
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006349:Heart Valve Diseases / Q000150:complications; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008712:Methicillin / Q000627:therapeutic use; D008875:Middle Aged; D010403:Penicillin Resistance; D011183:Postoperative Complications; D013203:Staphylococcal Infections
chemical_list: D000900:Anti-Bacterial Agents; D008712:Methicillin; D002512:Cephalothin
references.citation: Am J Cardiol. 1970 May;25(5):602-7
references.pmid: 4909696
references.citation: J Med Microbiol. 1972 Feb;5(1):9-19
references.pmid: 4260010
references.citation: Am J Med. 1975 Nov;59(5):660-73
references.pmid: 1106192
references.citation: Circulation. 1973 Aug;48(2):365-77
references.pmid: 4580035
references.citation: J Clin Pathol. 1969 Jul;22(4):475-82
references.pmid: 5798636
references.citation: Medicine (Baltimore). 1977 Jul;56(4):287-313
references.pmid: 875718
references.citation: Ann N Y Acad Sci. 1974 Jul 31;236(0):7-14
references.pmid: 4607662
references.citation: Antimicrob Agents Chemother (Bethesda). 1963;161:635-42
references.pmid: 14274976
references.citation: Chest. 1971 Feb;59(2):198-202
references.pmid: 5100821
references.citation: Am J Med. 1978 Feb;64(2):199-206
references.pmid: 629268
references.citation: Mayo Clin Proc. 1968 Jun;43(6):420-34
references.pmid: 5190668
references.citation: Circulation. 1973 Jun;47(6):1319-26
references.pmid: 4709547
references.citation: J Infect Dis. 1978 Mar;137(3):245-50
references.pmid: 632623
references.citation: Medicine (Baltimore). 1978 Mar;57(2):105-27
references.pmid: 622043
references.citation: Ann Intern Med. 1975 Jun;82(6):751-6
references.pmid: 1138584
references.citation: Prog Cardiovasc Dis. 1973 Nov-Dec;16(3):239-74
references.pmid: 4593514
references.citation: Arch Intern Med. 1973 Aug;132(2):216-20
references.pmid: 4489733
references.citation: Antimicrob Agents Chemother. 1975 Feb;7(2):153-8
references.pmid: 1137366
references.citation: J Clin Pathol. 1973 Jul;26(7):517-22
references.pmid: 4727060
references.citation: Ann Intern Med. 1970 Mar;72(3):341-8
references.pmid: 4984425